The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 05, 2008
Filed:
Jun. 21, 2005
Sarma Duddu, Redwood City, CA (US);
Srinivas Palakodaty, Foster City, CA (US);
David Lechuga-ballesteros, San Jose, CA (US);
Danforth Miller, San Carlos, CA (US);
Alan R. Kugler, Montara, CA (US);
Christopher Frantz, Sunnyvale, CA (US);
Trixie Tan, Daly City, CA (US);
Richard Malcolmson, San Mateo, CA (US);
Keith Washco, Fremont, CA (US);
Theresa Sweeney, El Granada, CA (US);
Thomas E. Tarara, Burlingame, CA (US);
Sarvajna Dwivedi, Redwood City, CA (US);
Michael A. Eldon, Redwood City, CA (US);
Sarma Duddu, Redwood City, CA (US);
Srinivas Palakodaty, Foster City, CA (US);
David Lechuga-Ballesteros, San Jose, CA (US);
Danforth Miller, San Carlos, CA (US);
Alan R. Kugler, Montara, CA (US);
Christopher Frantz, Sunnyvale, CA (US);
Trixie Tan, Daly City, CA (US);
Richard Malcolmson, San Mateo, CA (US);
Keith Washco, Fremont, CA (US);
Theresa Sweeney, El Granada, CA (US);
Thomas E. Tarara, Burlingame, CA (US);
Sarvajna Dwivedi, Redwood City, CA (US);
Michael A. Eldon, Redwood City, CA (US);
Nektar Therapeutics, San Carlos, CA (US);
Abstract
A composition includes particles including at least about 95 wt % of amphotericin B, wherein the particles have a mass median diameter ranging from about 1.1 μm to about 1.9 μm. Another composition also includes particles including at least about 95 wt % of amphotericin B, wherein at least about 80 wt % of the particles have a geometric diameter ranging from about 1.1 μm to about 1.9 μm. Yet another composition includes particles including amphotericin B, wherein the particles have a mass median diameter less than about 1.9 μm, and wherein the amphotericin B has a crystallinity level of at least about 20%. Unit dosage forms, delivery systems, and methods may involve similar compositions.